Research Library
Peptide Research, Explained
Evergreen guides on purity, documentation, handling, and the compounds themselves — written as research and procurement education. For laboratory research use only.

PT-141 US Regulatory Status: A Primary-Source Summary
A neutral, dated reading of primary US sources (FDA and the Federal Register) relevant to PT-141 and research peptides, with what each document does and does not say.
Read article →
BPC-157 and TB-500: US Regulatory Documents in 2026
A side-by-side reading of what FDA, HHS and WADA documents state about BPC-157 and TB-500 in 2026, quoted with dates and no legal conclusion.
Read article →
BPC-157 Regulatory Documents in 2026: A Dated Reading
A dated reading of the FDA, HHS and WADA documents that name BPC-157 in 2026, quoted from the primary text with no legal conclusion.
Read article →
Tirzepatide: FDA, HHS and WADA Documents Read
What FDA approval and shortage documents, the HHS 30 October 2026 notice and the WADA 2026 List state about tirzepatide, with dates and no legal conclusions.
Read article →
Research Peptide Documents in 2026: HHS, FDA and WADA Read
What the HHS notice of 30 October 2026, FDA pages and meeting materials, and the WADA 2026 List state about named peptides, with dates and no legal conclusions.
Read article →5 articles in Regulatory